EUVIMEDEUVIMED entdecken
Crossref

Epidemiology of supplemental oxygen in patients with pulmonary hypertension

Rodrigo Torres-Castro, Williams Hinojosa, Amaya Martínez-Meñaca, Ernest Sala Llinas, Josefa Jiménez Arjona, Joaquín Rueda Soriano, Agueda Aurtenetxe, Joan Albert Barberà, Pilar Escribano-Subías, Isabel Blanco iD, REHAP Investigators

Respirology · 2025

DOI: 10.1111/resp.14821 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respirology, 2025. Verfasst von Rodrigo Torres-Castro und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Hospital Clínic, University of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Oxygen Inhalation Therapy, Hypertension, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Societat Catalana de Pneumologia, Sociedad Española de Neumología y Cirugía Torácica.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Patients with pulmonary hypertension (PH) may present with hypoxaemia at rest or during daily activities. There is no epidemiological data on the prescription of long‐term oxygen therapy (LTOT) in patients with PH. The study sought to analyse the prevalence and incidence of LTOT prescription among patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH) in Spain and to determine predictors for this prescription.

Methods

A retrospective analysis was performed from the Spanish Registry of Pulmonary Arterial Hypertension (REHAP). Collected data included demographics and anthropometric measurements, functional class (FC), arterial blood gases, pulmonary function tests, haemodynamic measurements, six‐minute walking distance (6MWD) and LTOT prescription. In addition, we assessed the prevalence and incidence of LTOT prescription by PH group and subtype and potential predictors for LTOT initiation in the first 5 years after diagnosis.

Results

We analysed 4533 patients (69.9% PAH and 30.1% CTEPH), mostly female (64.5%), with a mean age of 53.0 ± 18.3 years. The prevalence of LTOT was 19.3% for all patients. The incidence of LTOT prescriptions decreased from 5.6% to 1.6% between 2010 and 2019, respectively. Predictors for LTOT prescription, excluding those that represent the indication for oxygen therapy were: FC (HR: 1.813), 6MWD (HR: 1.002), mean pulmonary arterial pressure (mPAP) (HR: 1.014), cardiac index (CI) (HR: 1.253), pulmonary vascular resistance (PVR) (HR: 1.023) and diffusing capacity of carbon monoxide (DL CO ) (HR: 1.294).

Conclusion

The prevalence of LTOT in PAH and CTEPH patients is close to 20%. FC, 6MWD, mPAP, CI, PVR and DL CO were predictors for LTOT prescription. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oxygen Inhalation TherapyHypertension, PulmonaryHumansFemaleMaleMiddle AgedRetrospective StudiesSpainAdultAgedRegistriesPrevalenceIncidence

Stichwörter der Autor:innen

chronic thromboembolic pulmonary hypertensionincidencelong‐term oxygen therapyprevalencepulmonary arterial hypertension

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), University of Barcelona, Barcelona, Spain.
  • Department of Physical Therapy, Faculty of Medicine, University of Chile, Santiago, Chile.
  • Pulmonary Hypertension Unit, Department of Cardiology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Department of Pneumology, Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Instituto de Investigación Valdecilla (IDIVAL), Santander, Spain.

ORCID-Profile: Isabel Blanco

Förderung

  • Instituto de Salud Carlos III
  • Societat Catalana de Pneumologia
  • Sociedad Española de Neumología y Cirugía Torácica
  • Fondo Europeo de Desarrollo Regional (FEDER)
  • Una manera de hacer Europa
  • National Agency for Research and Development (ANID)/Scholarship Program/DOCTORADO BECAS
  • Agencia Nacional de Investigación y Desarrollo

Zitieren

APA

Torres-Castro, R., Hinojosa, W., Martínez-Meñaca, A., Sala Llinas, E., Jiménez Arjona, J., Rueda Soriano, J., Aurtenetxe, A., Barberà, J. A., Escribano-Subías, P., Blanco, I., & REHAP Investigators (2025). Epidemiology of supplemental oxygen in patients with pulmonary hypertension. Respirology. https://doi.org/10.1111/resp.14821

Vancouver

Torres-Castro R, Hinojosa W, Martínez-Meñaca A, Sala Llinas E, Jiménez Arjona J, Rueda Soriano J, et al. Epidemiology of supplemental oxygen in patients with pulmonary hypertension. Respirology. 2025. doi:10.1111/resp.14821

BibTeX
@article{TorresCastro2025,
  author = {Torres-Castro, Rodrigo and Hinojosa, Williams and Martínez-Meñaca, Amaya and Sala Llinas, Ernest and Jiménez Arjona, Josefa and Rueda Soriano, Joaquín and Aurtenetxe, Agueda and Barberà, Joan Albert and Escribano-Subías, Pilar and Blanco, Isabel and REHAP Investigators, REHAP Investigators},
  title = {Epidemiology of supplemental oxygen in patients with pulmonary hypertension},
  journal = {Respirology},
  year = {2025},
  doi = {10.1111/resp.14821}
}
Kostenlos starten →